The Cost Effectiveness of Lisdexamfetamine Dimesylate for the Treatment of Binge Eating Disorder in the USA
Crossref DOI link: https://doi.org/10.1007/s40261-016-0381-3
Published Online: 2016-02-25
Published Print: 2016-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ágh, Tamás
Pawaskar, Manjiri
Nagy, Balázs
Lachaine, Jean
Vokó, Zoltán
Funding for this research was provided by:
Shire Development LLC (Wayne, PA, US)
License valid from 2016-02-25